<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220102053595N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-02-17</date_registration>
      <primary_sponsor>Islamic Azad University</primary_sponsor>
      <public_title>The effect of propolis supplementation in hemodialysis patients</public_title>
      <acronym></acronym>
      <scientific_title>The effect of 8 weeks of aerobic exercise with propolis supplementation on biomarkers of oxidative stress in hemodialysis patients</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-02-19</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/61881</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Randomization description: Among the patients with renal failure undergoing hemodialysis referred to Ale Muhammad Medical polyclinic and Emergency service in Mashhad, 60 patients will be selected based on inclusion criteria and personal satisfaction and will be matched according to age and gender, then randomly assigned to one of four intervention and control groups. Patients will be randomly divided into intervention and control groups using statistical software and block randomization, Blinding description: The capsules are standardized in all groups in terms of appearance, color, and odor. From the selection of the person, no one will be aware of the type of treatment he/she will receive. Finally, data and information are given to the statistician with a special code for each group, so that the statistician can also be blinded.</study_design>
      <phase>N/A</phase>
      <hc_freetext>End stage renal disease.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: the first group received 500 mg of propolis per day, 2  capsules containing 250 mg Propolis extract, 1 capsule before lunch, and 1 capsule before dinner, with 3 days a week exercise program with a stationary bike according to the protocol for 8 weeks. Propolis capsules have been prepared by Shahdineh Golha Honey Company located in Najafabad, Isfahan, and propolis extract has been extracted alcoholically. Intervention 2: Intervention group: the second group received 500 mg of propolis per day, 2 capsules containing 250 mg Propolis extract, 1 capsule before lunch, and 1 capsule before dinner, without exercise for 8 weeks. Propolis capsules have been prepared by Shahdineh Golha Honey Company located in Najafabad, Isfahan, and propolis extract has been extracted alcoholically. Intervention 3: Control group: the third group received 500 mg of placebo per day, 2capsules containing 250 mg placebo, 1 capsule before lunch, and 1 capsule before dinner, with 3 days a week exercise program with stationary bike according to the protocol for 8 weeks. Intervention 4: Control group: the fourth group received 500 mg of placebo per day, 2 capsules containing 250 mg placebo extract, 1 capsule before lunch, and 1 capsule before dinner, without exercise for 8 weeks.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Individually nonidentifiable information of participants will be shared in this study. Also, the protocol, results and statistical analysis of the study will be published in the relevant articles.

When:
Unidentifiable personal information of the participants will be available after the publication of the related articles.

To whom:
Unidentifiable personal information of the participants will be made available to other researchers at academic institutions.

Conditions:
Unidentifiable personal information of participants can only be used for research

Where to obtain:
send an email: hamidipour.sina.nu@mshdiau.ac.ir

How to obtain:
Researchers in academic institutions can send their request by e-mail to the mentioned email. The data will be sent to them after consulting and approving the research team.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Sina Hamidi pour</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Ostad Yusofi Street, Emamieh Boulevard ,GhasemAbad, Mashhad, Iran.</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9187147578</zip>
        <telephone>+98 51 3661 3379</telephone>
        <email>hamidipour.sina.nu@mshdiau.ac.ir</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Zohre Amir khani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Ostad Yusofi Street, Emamieh Boulevard ,GhasemAbad, Mashhad, Iran.</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9187147578</zip>
        <telephone>+98 51 3661 3379</telephone>
        <email>sahar56h@yahoo.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>An age range of 18 to 65 years
ESRD patients on hemodialysis treatment
Perform hemodialysis 3 days a week
Absence of any physical abnormalities or bone diseases that interfere with their physical activity
Willingness to participate in research</inclusion_criteria>
      <agemin>30 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>BMI above 30 kg/m
Disease (gallstones, cancer, and acute disease)
Acute heart accident in the past year
Taking any medicine outside the routine treatment protocol of hemodialysis patients
Use of oral and injectable nutritional supplements except nephrovit and iron supplements according to the protocol
Any allergy to honey and its compounds
Leaving the patient with his/her personal consent
Smoking, drug addiction or alcohol consumption</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>N18.5</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Chronic kidney disease, stage 5</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Placebo</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: the first group received 500 mg of propolis per day, 2  capsules containing 250 mg Propolis extract, 1 capsule before lunch, and 1 capsule before dinner, with 3 days a week exercise program with a stationary bike according to the protocol for 8 weeks. Propolis capsules have been prepared by Shahdineh Golha Honey Company located in Najafabad, Isfahan, and propolis extract has been extracted alcoholically.</i_keyword>
      <i_keyword>Intervention group: the second group received 500 mg of propolis per day, 2 capsules containing 250 mg Propolis extract, 1 capsule before lunch, and 1 capsule before dinner, without exercise for 8 weeks. Propolis capsules have been prepared by Shahdineh Golha Honey Company located in Najafabad, Isfahan, and propolis extract has been extracted alcoholically.</i_keyword>
      <i_keyword>Control group: the third group received 500 mg of placebo per day, 2capsules containing 250 mg placebo, 1 capsule before lunch, and 1 capsule before dinner, with 3 days a week exercise program with stationary bike according to the protocol for 8 weeks</i_keyword>
      <i_keyword>Control group: the fourth group received 500 mg of placebo per day, 2 capsules containing 250 mg placebo extract, 1 capsule before lunch, and 1 capsule before dinner, without exercise for 8 weeks</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Malondialdehyde. Timepoint: At the beginning and end of the study. Method of measurement: kit.</prim_outcome>
      <prim_outcome>Total antioxidant capacity. Timepoint: At the beginning and end of the study. Method of measurement: kit.</prim_outcome>
      <prim_outcome>Systolic blood pressure. Timepoint: At the beginning and end of the study. Method of measurement: Mercury manometers.</prim_outcome>
      <prim_outcome>Diastolic blood pressure. Timepoint: At the beginning and end of the study. Method of measurement: Mercury manometers.</prim_outcome>
      <prim_outcome>Nutritional status. Timepoint: At the beginning and end of the study. Method of measurement: Food recall and 3-day food record questionnaires.</prim_outcome>
      <prim_outcome>Anthropometric indicators. Timepoint: At the beginning and end of the study. Method of measurement: Weighing scale, Tape measure, BIA.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Personal financial source</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-01-19</approval_date>
        <contact_name>Research Ethics Committees of Islamic Azad University- Mashhad Branch</contact_name>
        <contact_address>Floor 13, Block A, Ministry of Health &amp; Medical Education Headquarters, Between Zarafashan &amp; South Falamak, Qods Town, Tehran, Iran. Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
